"Another competitor in the breast cancer space is Medifocus (OTCMKTS:MDFZF). The company is developing and commercializing minimally invasive treatment systems used in the treatment of cancerous and benign tumors. Medifocus has various platforms currently being developed but the one applicable to breast cancer is the APA 1000 breast cancer treatment system. The goal of the system is to destroy localized breast tumors through the application of heat alone or in combination with chemotherapy. The company has already received regulatory approval to begin its Phase III trial."
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.